期刊文献+

低分子肝素钙在岛状皮瓣静脉危象抢救中的临床应用 被引量:10

Clinical application of low-molecular-weight heparin(Fraxiparine) in rescuing venous crisis of island skin flap
暂未订购
导出
摘要 目的探讨应用低分子肝素钙和应用皮瓣放血、按摩法等措施在抢救岛状皮瓣静脉危象临床效果的比较。方法 73例岛状皮瓣静脉危象,应用低分子肝素钙皮下注射47例(Ⅰ组),26例应用皮瓣放血、按摩法(Ⅱ组)。应用低分子肝素钙后监测活化部分凝血酶时间测定(activated partial thromboplastin time,APTT),活化凝血因子Ⅹ(Ⅹa),活化凝血因子Ⅱ(Ⅱa)活性。结果应用低分子肝素钙皮瓣成活率为(87.46±8.54)%明显高于应用对照组(34.37±6.43%),P<0.001;APTT在应用低分子肝素钙前后(0、2、4 h)明显延长(24.28±6.71、41.35±7.64、32.34±6.35),P<0.01;Ⅹa活性在应用低分子肝素钙前后(0、2、4 h)明显降低(152.4±30.7、65.8±24.4、83.4±18.4),P<0.01;Ⅱa活性在应用低分子肝素钙(0、2、4 h)为(155.70±31.61、143.20±24.75、143.4±23.35,P=NS,没有明显差异。结论应用低分子肝素钙抢救岛状皮瓣静脉危象,可大大提高皮瓣成活率,且没有对患者全身凝血功能造成不良影响。 Objective To evaluate the clinical efficacy of low molecular weight heparin(Fraxiparine) in rescuing venous crisis of island skin flap.Methods Of the 73 patients with venous crisis of island skin flap,47 received subcutaneous injection of low-molecular-weight heparin(group I) and 26 were treated with phlebotomy,local compression and topical application of unfractionated heparin solution gauze(group II).Results The flap survival ratio was(88.46±8.64)% in group I and(38.37±6.53)% in group II(P〈0.001).At 0,2,and 4 h after injection of low-molecular-weight heparin,the activated partial thromboplastin time(APTT) was obviously delayed(24.28±6.71,41.35±7.64 and 32.34±6.35,respectively,P0.01),FXa:C level was significantly decreased(152.4±30.7,65.8±24.4 and 83.4±18.4,respectively,P〈0.01),while FIIa:C level underwent no obvious alterations(155.70±31.61,143.20±24.75,and 143.4±23.35,respectively,P=NS).Conclusion Fraxiparine has good antihrombotic efficacy in rescuing venous crisis of island skin flap without adverse effect on systemic coagulation. Kay words: venous crisis;low-molecular-weight heparin;island skin flap
出处 《南方医科大学学报》 CAS CSCD 北大核心 2011年第9期1582-1584,共3页 Journal of Southern Medical University
基金 广东省自然科学基金070020) 广东省医学科学技术研究基金(A200703)
关键词 静脉危象 低分子肝素钙 岛状皮瓣 tomography X-ray computed angiography digital model virtual technology virtual endoscope colonic neoplasms
  • 相关文献

参考文献11

  • 1Bielecki M, Karpik M, Skowroflski J, et al. The effect of prophylactic doses of nadroparin and therapeutic doses of betamethasone on skin flap survival in rats [J]. Folia Histochem Cytobiol, 2009, 47(4): 673-7.
  • 2Ritter MM, Cronan JC, Ruder AM, et al. Improve microsurgical anastomotical patency with low molecular weight heparin [J]. J Reconstr Microsurg, 1998,14(5): 331-6.
  • 3曹艳,杨国荣,屈希珍,王欣,廉更.额部皮瓣移转术后静脉危象的抢救体会[J].中华整形外科杂志,2002,18(S1):198-201. 被引量:1
  • 4Bergqvist D. Low molecular weight heparins [J]. J Intern Med, 1996, 240(1): 63-72.
  • 5Frampton JE, Diana Faulds. Parnaparin areviwe of its pharmacology and clinical application in the prevention and treatment of thromboembolic and other vascular disorders [J]. Drugs, 1994, 47 (4): 652-76.
  • 6许俊堂,胡大一.如何理解低分子肝素在治疗不稳定性冠状动脉疾病随机对照试验中结果的不同[J].中国医药导刊,2000,2(3):19-22. 被引量:7
  • 7徐军,林华.局部输入低剂量肝素提高肌皮瓣继发性静脉淤血存活率的实验[J].中华整形外科杂志,2001,17(3):148-150. 被引量:10
  • 8Miyawaki T, Jackson IT, Elmazar H, et al. The effect of low-molecular-weight heparin in the survival of a rabbit congested skin flap[J]. Plast Reconstr Surg, 2002, 109(6): 1994-9.
  • 9Bielecki M, Karpik M, Skowroflski J, et al. The effect of prophyl- actic doses of nadroparin and therapeutic doses of betamethasone on skin flap survival in rats[J]. Folia Histochem Cytobiol, 2009, 47 (4): 673-7.
  • 10李玉林.病理学[M].7版.北京:人民卫生出版社,2008:1.

二级参考文献13

  • 1范启申,王成琪,魏长月,张希利,泮兆勋.小儿断指再植中几个主要问题探讨[J].中华显微外科杂志,1994,17(1):17-19. 被引量:28
  • 2Li X,Microsurg,1992年,13卷,208页
  • 3Lee C,Plast Reconstr Surg,1992年,89卷,1092页
  • 4Wong L,Ann Plast Surg,1991年,26卷,221页
  • 5Cohen M,Demers C,Gurfinkel EP,et al.For the Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group.A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery desease[].The New England Journal of Medicine.1997
  • 6Antman EM,McCabe CH,Premmereur J,et al.Enoxaparin for the acute and chronic management of unstable angina/non-Q wave myocardial infarction: results of TIMI 11B[].Circulation.1998
  • 7Oler A,Whooley MA,Oler J,et al.Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina[].The Journal of The American Medical Association.1996
  • 8Gurfinkel EP,Manos EJ,Mejail RI,et al.Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia[].Journal of the American College of Cardiology.1995
  • 9Antman EM,Cohen M,Radley D,et al.Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction.TIMI 11B-ESSENCE meta-analysis[].Circulation.1999
  • 10Antman EM,McCabe CH,Gurfinkel EP,et al.Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction.Results of the thrombolysis in myocardial infarction (TIMI) 11B trial[].Circulation.1999

共引文献105

同被引文献74

引证文献10

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部